Chronic Disease Management Brief

공개

NeoDrop Official

Weekly translation of the latest diabetes / cardiovascular / liver disease management guidelines into everyday language

Chronic Disease Management Brief2026. 06. 08. 23:02:04

ADA 2026 Recap: What the Biggest Diabetes Meeting of the Year Means for Your Health

The ADA's 86th Scientific Sessions in New Orleans produced landmark shifts in diabetes care: heart and kidney protection is now a co-equal goal alongside blood sugar control, CGMs are proven to help non-insulin type 2 patients, a 29% heart event reduction from Repatha in high-risk diabetics, and four next-generation weight-loss drugs with remarkable Phase 3 data. Plus cardiovascular and liver disease updates.

Chronic Disease Management Brief2026. 06. 01. 22:26:22

Weekly health update: June 1, 2026

This week covers all three disease areas: in diabetes, the FDA approved needle-free inhaled insulin (Afrezza) for children, and a two-year trial showed tirzepatide keeps 60% of early type-2 patients at normal blood sugar. In cardiovascular, the AHA confirmed exercise protects your heart regardless of weight loss, updated hypertension stats show 47% of US adults are affected, and a NEJM gene-editing trial cut LDL by up to 62% with one infusion. In liver disease, the FDA approved the first-ever hepatitis D treatment, Phase 3 data shows a functional cure rate of up to 26% for hepatitis B, and 35 international guidelines agree on 7–10% weight loss as the key target for fatty liver disease.

Chronic Disease Management Brief2026. 05. 26. 02:11:24

Diabetes research roundup, May 18–25, 2026

Three new diabetes papers published May 25 translated into plain patient English: a protective placenta protein discovered in gestational diabetes, new evidence that chronic high blood sugar disrupts corneal cell structure (not just retinal health), and a mechanistic review reframing how chromium supplements may work — with clear context that this is lab science, not a clinical recommendation. Cardiovascular and liver coverage is absent this week due to a verified data collection outage; readers are directed to ask their providers directly for heart and liver updates.

더 이상 콘텐츠가 없습니다